StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA)

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $6.00 price target on shares of Arcadia Biosciences in a report on Wednesday, August 21st.

Arcadia Biosciences Stock Performance

Shares of RKDA stock opened at $2.76 on Friday. The company’s 50-day simple moving average is $3.33 and its 200-day simple moving average is $3.06. Arcadia Biosciences has a one year low of $1.85 and a one year high of $5.34. The stock has a market capitalization of $3.75 million, a price-to-earnings ratio of -0.64 and a beta of 1.27.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.